Study for molecular mechanism of human lung adenocarcinoma.
人肺腺癌分子机制研究。
基本信息
- 批准号:14370065
- 负责人:
- 金额:$ 8.13万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
For the three years, we mainly performed the following three research projects to make clear the molecular mechanisms of the pathogenesis and the malignant progression of the lung adenocarcinoma.1.The expression profile of adenoma induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse was compared with that of normal lung tissue by suppression subtractive hybridization (SSH). The mRNAs of surfactant-associated protein A (SP-A) and lysozyme showed characteristically higher transcription in the adenoma tissue than normal lung.2.We established an immortalized human atypical adenomatous hyperplasia (AAH) cell line (PL16T) and a human non-neoplastic bronchial epithelial cell line (PL16B) from the same patient. The expression profile of PL16T was compared with that of PL16B by SSH method. The characteristically high transcription of tumor-associated calcium signal transducer 2 (TACSTD2) and S100 calcium binding protein A2 (S100A2) was detected in PL16T. Our findings indicate that TACSTD2 and S100A2 are selectively and highly expressed in AAH, which is preinvasive stage of lung adenocaricnoma, and the high expression is preserved until the lesion progresses to bronchioloalveolar carcinoma (BAC), which is in situ stage of human lung adenocarcinoma and more advanced stages.3.Using the resected material of human lung adenocarcinoma case, the expression profile of advanced area in Noguchi type C adenocarcinoma (early but advanced bronchioloalveolar carcinoma) was compared with that of in situ lesion of the same case by SSH method. The significantly high transcription of Bax inhibitor-1 (BI-1), TACSTDI, mitochondrial cytochrome c oxidase II, and FJL12770 was detected in adnvanced lesion. The BI-1 gene expression in tumor specimens was significantly higher in BAC and carcinoma with bronchioloalveolar (BA) spreading than carcinomas without BA component. The BI-1 gene expression was restricted to the tumor cells with lepidic growth.
三年来,我们主要开展了以下三个方面的研究工作,旨在阐明肺腺癌发生和发展的分子机制。1.应用抑制性消减杂交技术比较4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone诱导的A/J小鼠腺瘤和正常肺组织的表达谱。肺表面活性物质相关蛋白A(SP-A)和溶菌酶的mRNAs在肺腺瘤组织中的转录水平明显高于正常肺组织。2.建立了永生化的人非典型腺瘤性增生(AAH)细胞系(PL16T)和来自同一患者的人非肿瘤性支气管上皮细胞系(PL16B)。用SSH方法比较PL16T和PL16B的表达谱。在PL16T中检测到肿瘤相关钙信号转导蛋白2(TACSTD2)和S100钙结合蛋白A2(S100A2)的高转录。我们的研究结果表明,TACSTD2和S100A2在肺腺癌的侵袭前期AAH中选择性地高表达,并持续高表达,直到病变进展到细支气管肺泡癌(BAC),后者是人类肺腺癌的原位阶段和更晚期。3.利用人肺腺癌病例的切除材料,用SSH方法比较了野口C型腺癌(早期和晚期细支气管肺泡癌)和同一病例的原位病变组织中晚期区的表达情况。进展期病变中Bax抑制因子-1(BI-1)、TACSTDI、线粒体细胞色素C氧化酶II和FJL12770的转录水平显著升高。BAC和有细支气管肺泡(BA)扩散的癌组织中BI-1基因表达显著高于无BA成分的癌组织。BI-1基因的表达仅限于恶性生长的肿瘤细胞。
项目成果
期刊论文数量(80)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Anthracotic index and DNA methylation status of sputum contents can be used for identifying the population at risk of lung cancer.
炭疽指数和痰内容物DNA甲基化状态可用于识别肺癌风险人群。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:光田 輝彦;中川 敏幸;Tanaka R;Yamada K;Asamura H;Onizawa K;Okubo C;Noguchi M;Tanaka R;Minami Y;Minami Y;Travis W.D.;Sakai M;Shimada A;Minami Y;Iijima T;Nakamura N;Konno S
- 通讯作者:Konno S
The implication of background anthracosis in the development and progression of pulmonary adenocarcinoma.
背景炭疽病在肺腺癌发生和进展中的意义。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Wang D
- 通讯作者:Wang D
Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis.
通过组织病理学和核分析分析小型原发性肺腺癌的预后。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Nagano H;Minami Y
- 通讯作者:Minami Y
Minami Y: "Cytologic characteristic of pulmonary papillary adenoma : A case report"Acta Cytologica. (in press).
Minami Y:“肺乳头状腺瘤的细胞学特征:病例报告”细胞学学报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomori H: "A case of multiple adenomatous hyperplasia of the lung. Detected by computed tomography"Jpn J Clin Oncol. 31・10. 514-516 (2001)
野森H:“肺部多发性腺瘤性增生的病例。通过计算机断层扫描检测”Jpn J Clin Oncol 31・10(2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOGUCHI Masayuki其他文献
Interaction of VRK2 with Akt at lysosomes controls induction of autophagy
VRK2 与 Akt 在溶酶体上的相互作用控制自噬的诱导
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
NOGUCHI Masayuki;HIRATA Noriyuki;SUIZU Futoshi - 通讯作者:
SUIZU Futoshi
NOGUCHI Masayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOGUCHI Masayuki', 18)}}的其他基金
Molecular analysis of the Rac1 activation for malignant progression of early lung adenocarcinoma via ECT2-FAK binding
通过 ECT2-FAK 结合对 Rac1 激活对早期肺腺癌恶性进展的分子分析
- 批准号:
20K07388 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modulation of Akt kinase activity by ubiquitination
通过泛素化调节 Akt 激酶活性
- 批准号:
22370046 - 财政年份:2010
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of the molecular mechanisms of Akt activation
Akt 激活分子机制的表征
- 批准号:
17370044 - 财政年份:2005
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Quantification of multiple mRNAs expressions in microdissected specimens : Development of liquid
显微解剖标本中多种 mRNA 表达的定量:液体的开发
- 批准号:
10557119 - 财政年份:1998
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies of genetic altarations in pcecancerous and background lesions by tissue microdissection.
通过组织显微切割研究原癌和背景病变的遗传变异。
- 批准号:
08670233 - 财政年份:1996
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development
以高通量将表型特征与单细胞基因表达谱联系起来,用于药物发现和细胞疗法开发
- 批准号:
10482180 - 财政年份:2022
- 资助金额:
$ 8.13万 - 项目类别:
Elucidation of the gene expression profile of bifidobacteria in the gut microbiota: development of selective recovery method
阐明肠道微生物群中双歧杆菌的基因表达谱:开发选择性恢复方法
- 批准号:
20H02893 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of the single-cell expression profile and immune status of replication repair deficient glioma
复制修复缺陷神经胶质瘤的单细胞表达谱和免疫状态的表征
- 批准号:
449812 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
Studentship Programs
Glycan expression profile of schirrhous gastric cancer
硬质胃癌的聚糖表达谱
- 批准号:
20K09097 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Search for new targets of endometriosis therapy based on gene expression profile by AI
AI基于基因表达谱寻找子宫内膜异位症治疗新靶点
- 批准号:
19K22688 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Establish of innovative diagnostic of fatal hypothermia by systematic gene expression profile in hypothermia-related tissues
通过低温相关组织的系统基因表达谱建立致命低温的创新诊断
- 批准号:
19K10688 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ontogenetic trajectory and gene expression profile of hybrid phenotypic effects in mammals
哺乳动物杂种表型效应的个体发生轨迹和基因表达谱
- 批准号:
540652-2019 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
University Undergraduate Student Research Awards
Expression profile analyses and target identification of the small RNA MarS in Streptococcus pyogenes: a transcriptome based study
化脓性链球菌中小 RNA MarS 的表达谱分析和靶点鉴定:基于转录组的研究
- 批准号:
420051101 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
Research Grants
Gene expression profile and therapeutic targets in high-grade spindle cell sarcomas focusing on the gene regulation system.
高级别梭形细胞肉瘤的基因表达谱和治疗靶点,重点关注基因调控系统。
- 批准号:
19K16753 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gene expression profile in short-pulse retinal photocoagulation
短脉冲视网膜光凝中的基因表达谱
- 批准号:
19K18845 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists